Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hallmarks of pancreatic cancer: spotlight on TAM receptors.

EBioMedicine - 1 Sept 2024

Vázquez-Bellón Núria, Martínez-Bosch Neus, García de Frutos Pablo, Navarro Pilar

Abstract excerpt

Pancreatic ductal adenocarcinoma (PDAC) represents the most prevalent type of pancreatic cancer and ranks among the most aggressive tumours, with a 5-year survival rate of less than 11%. Projections indicate that by 2030, it will become the second leading cause of cancer-related deaths. PDAC presents distinctive hallmarks contributing to its dismal prognosis: (i) late diagnosis, (ii) heterogenous and complex...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Axl Receptor Tyrosine Kinase
Share to Biomarkers, Tumor
Share to c-Mer Tyrosine Kinase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Pancreatic Ductal

Share to Pancreatic Neoplasms

Share to Proto-Oncogene Proteins

Share to Receptor Protein-Tyrosine Kinases

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 39137571
DOI: 10.1016/j.ebiom.2024.105278
PMCID: PMC11367522

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hallmarks of pancreatic cancer: spotlight on TAM receptors.PMID 39137571Read ↗

Molecular biology of pancreatic cancer.Semantic proximity Read ↗

Cellular and molecular aspects of pancreatic cancer.Semantic proximity Read ↗

Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward.Semantic proximity Read ↗

A Young Scientist's Guide to PDAC: Past, Present, and FutureSemantic proximity Read ↗

Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspectiveSemantic proximity Read ↗

AXL is a key factor for cell plasticity and promotes metastasis in pancreatic cancerSemantic proximity Read ↗

Pancreatic biomarkers: could they be the answer?Semantic proximity Read ↗

Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Reveals That TAM2-Driven Genes Affect Immunotherapeutic Response and Prognosis in Pancreatic CancerSemantic proximity Read ↗

Molecular mechanisms of pancreatic cancer and potential targets of treatment.Semantic proximity Read ↗

Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment.Semantic proximity Read ↗

The Heterogeneity of the Tumor Microenvironment as Essential Determinant of Development, Progression and Therapy Response of Pancreatic CancerSemantic proximity Read ↗

Molecular Pathology of Pancreatic Cancer: From Bench-to-Bedside TranslationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.